ArticleRSC advances2019
Kinetic inhibition effect of Type I and III antifreeze proteins on unidirectional tetrahydrofuran hydrate crystal growth.
Article in RSC advances, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 14 citations in OpenAlex.
- Measurement of Ice-Binding Protein Inhibition of Non-ice Crystal Growth.Methods in molecular biology (Clifton, N.J.) · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Experiments were performed to evaluate the kinetic inhibition effect of Type I and Type III antifreeze proteins (AFPs), polyvinyl alcohol (PVA) and polyvinylpyrrolidone (PVP) on the growth of tetrahydrofuran (THF) clathrate hydrate crystals using the unidirectional growth technique. The crystal growth interface shifted under an applied temperature gradient over a given time. Type I AFP was the most effective kinetic inhibitor, followed by PVP, Type III AFP and PVA. The morphology of the THF hydrate was affected significantly by the concentration of Type I AFP. At low concentrations of Type I AFP, a large hexagonal plate-like crystal formed. At high concentrations, the growth interface became relatively flat. Conversely, at low concentrations of Type III AFP, the morphology of the THF hydrate crystal was unaffected by the additive.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.